US 11,033,321 · Application 16/160,205 · Granted Jun 15, 2021
US 11,033,321
Tissue ablation with irreversible electroporation
Estimated expiration
December 21, 2024
Expired 632 days ago
Earliest effective filing
Dec 21, 2004
+ 20 years
Dec 21, 2024
PTA +304d
Oct 21, 2025
TD cap (US 8,282,631)
Dec 21, 2024
Final
Dec 21, 2024
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- October 15, 2018
- Earliest effective filing
- December 21, 2004
- Issue date
- June 15, 2021
- PTA
- +304 days
- Base expiry (before PTA)
- December 21, 2024
December 21, 2004 + 20 years = December 21, 2024 + 304 PTA days = October 21, 2025
- Divisional of application 14/639,632, filed Mar 5, 2015, issued as US 10,117,701
- Divisional of application 13/546,339, filed Jul 11, 2012, issued as US 9,005,189
- Divisional of application 13/237,199, filed Sep 20, 2011, issued as US 8,282,631
- Continuation of application 10/571,162, filed Oct 18, 2006, issued as US 8,048,067
- National stage entry of application PCTUS2004043477, filed Dec 21, 2004
- National stage entry of application PCTUS2004043477, filed Dec 21, 2004
- Continuation of application 10/571,162, filed Oct 18, 2006, issued as US 8,048,067
- National stage entry of application PCTUS2004043477, filed Dec 21, 2004
- Divisional of application 13/237,199, filed Sep 20, 2011, issued as US 8,282,631
- Continuation of application 10/571,162, filed Oct 18, 2006, issued as US 8,048,067
- National stage entry of application PCTUS2004043477, filed Dec 21, 2004
- Divisional of application 13/546,339, filed Jul 11, 2012, issued as US 9,005,189
- Divisional of application 13/237,199, filed Sep 20, 2011, issued as US 8,282,631
- Continuation of application 10/571,162, filed Oct 18, 2006, issued as US 8,048,067
- National stage entry of application PCTUS2004043477, filed Dec 21, 2004
- PRO60/532,588 — Provisional — not used for base term
- PRO60/532,588 — Provisional — not used for base term
- PRO60/532,588 — Provisional — not used for base term
- PRO60/532,588 — Provisional — not used for base term
- PRO60/532,588 — Provisional — not used for base term
- PRO60/532,588 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to December 21, 2024 (earliest expiring referenced patent: US 8,282,631)
US 8,048,067· Application 10/571,162Capping patent
Tissue ablation with irreversible electroporation
- Filing date
- Oct 18, 2006
- Earliest effective filing
- Dec 21, 2004
- Issue date
- Nov 1, 2011
- PTA
- +1352 days
- Calculated expiration
- Sep 3, 2028
National stage entry of PCTUS2004043477, filed Dec 21, 2004
Dec 21, 2004 + 20y + 1352d PTA = Sep 3, 2028
US 8,282,631· Application 13/237,199Capping patent
Tissue ablation with irreversible electroporation
- Filing date
- Sep 20, 2011
- Earliest effective filing
- Dec 21, 2004
- Issue date
- Oct 9, 2012
- PTA
- 0 days
- Calculated expiration
- Dec 21, 2024
Continuation of 10/571,162, filed Oct 18, 2006, issued as US 8,048,067
National stage entry of PCTUS2004043477, filed Dec 21, 2004
National stage entry of PCTUS2004043477, filed Dec 21, 2004
Dec 21, 2004 + 20y = Dec 21, 2024
US 10,010,666· Application 14/313,647
Balloon catheter method for reducing restenosis via irreversible electroporation
- Filing date
- Jun 24, 2014
- Earliest effective filing
- Mar 27, 2009
- Issue date
- Jul 3, 2018
- PTA
- +346 days
- Calculated expiration
- Mar 8, 2030
Continuation of 12/413,357, filed Mar 27, 2009
Mar 27, 2009 + 20y + 346d PTA = Mar 8, 2030
US 10,668,208· Application 15/988,408
Balloon catheter method for reducing restenosis via irreversible electroporation
- Filing date
- May 24, 2018
- Earliest effective filing
- Mar 27, 2009
- Issue date
- Jun 2, 2020
- PTA
- 0 days
- Calculated expiration
- Mar 27, 2029
Continuation of 14/313,647, filed Jun 24, 2014, issued as US 10,010,666
Continuation of 12/413,357, filed Mar 27, 2009
Continuation of 12/413,357, filed Mar 27, 2009
Mar 27, 2009 + 20y = Mar 27, 2029
US 11,033,321· Application 16/160,205(from application 16/160,205)
Tissue ablation with irreversible electroporation
- Filing date
- Oct 15, 2018
- Earliest effective filing
- Dec 21, 2004
- Issue date
- Jun 15, 2021
- PTA
- +304 days
- Calculated expiration
- Oct 21, 2025
Divisional of 14/639,632, filed Mar 5, 2015, issued as US 10,117,701
Divisional of 13/546,339, filed Jul 11, 2012, issued as US 9,005,189
Divisional of 13/237,199, filed Sep 20, 2011, issued as US 8,282,631
Continuation of 10/571,162, filed Oct 18, 2006, issued as US 8,048,067
National stage entry of PCTUS2004043477, filed Dec 21, 2004
National stage entry of PCTUS2004043477, filed Dec 21, 2004
Continuation of 10/571,162, filed Oct 18, 2006, issued as US 8,048,067
National stage entry of PCTUS2004043477, filed Dec 21, 2004
Divisional of 13/237,199, filed Sep 20, 2011, issued as US 8,282,631
Continuation of 10/571,162, filed Oct 18, 2006, issued as US 8,048,067
National stage entry of PCTUS2004043477, filed Dec 21, 2004
Divisional of 13/546,339, filed Jul 11, 2012, issued as US 9,005,189
Divisional of 13/237,199, filed Sep 20, 2011, issued as US 8,282,631
Continuation of 10/571,162, filed Oct 18, 2006, issued as US 8,048,067
National stage entry of PCTUS2004043477, filed Dec 21, 2004
Dec 21, 2004 + 20y + 304d PTA = Oct 21, 2025
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 16/160,205 · US 11,033,321
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 11,033,321: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11033321Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.